Literature DB >> 30113507

A multicenter, open-label, phase III study of Abcertin in Gaucher disease: Erratum.

.   

Abstract

Entities:  

Year:  2018        PMID： 30113507      PMCID： PMC6112868          DOI： 10.1097/MD.0000000000012066

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
In the article, “A multicenter, open-label, phase III study of Abcertin in Gaucher disease”,[ which appears in Volume 96, Issue 45 of Medicine, Table 1 contained incorrect information and the correct table appears below.
Table 1

Demographics and Baseline Clinical Characteristics of the Per Protocol Population.

Demographics and Baseline Clinical Characteristics of the Per Protocol Population.
  1 in total

1.  A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

Authors:  Beom Hee Lee; Ahmed Fathy Abdalla; Jin-Ho Choi; Amal El Beshlawy; Gu-Hwan Kim; Sun Hee Heo; Ahmed Megahed Hassan Megahed; Mona Abdel Latif Elsayed; Tarik El-Sayed Mohammad Barakat; Khaled Mohamed Abd El-Azim Eid; Mona Hassan El-Tagui; Mona Mohamed Hamdy Mahmoud; Ekram Fateen; June-Young Park; Han-Wook Yoo
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.